Long-Term Outcome of the Management of Chronic Neuropathic Pain: A Prospective Observational Study

Journal of Pain

Volumn 16, Issue 9, 2015, Pages 852-861

  Moulin, Dwight E ^a   Clark, A John ^b,c   Gordon, Allan ^d   Lynch, Mary ^b,c   Morley Forster, Patricia K ^a   Nathan, Howard ^e   Smyth, Cathy ^e   Toth, Cory ^f   Vandenkerkhof, Elizabeth ^g   Gilani, Ammar ^h   Ware, Mark A ⁱ  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

^g QUEEN S UNIVERSITY   (Canada)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ MCGILL UNIVERSITY   (Canada)

Author keywords

chronic neuropathic pain; long term outcome; opioid treatment; Prospective cohort study

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CANNABINOID; LOCAL ANESTHETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; NARCOTIC ANALGESIC AGENT;

ACUPUNCTURE; ADULT; ARTICLE; BRIEF PAIN INVENTORY; CHRONIC PAIN; COMPENSATION; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; MALE; MOOD; MULTICENTER STUDY; NEUROPATHIC PAIN; OBSERVATIONAL STUDY; PAIN ASSESSMENT; PAIN INTENSITY; PATIENT SATISFACTION; PHYSIOTHERAPY; PROSPECTIVE STUDY; PSYCHOTHERAPY; QUALITY OF LIFE; SMOKING; TERTIARY HEALTH CARE; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT OUTCOME; AGED; CANADA; CHI SQUARE DISTRIBUTION; CHRONIC DISEASE; CLINICAL TRIAL; LONGITUDINAL STUDY; MIDDLE AGED; NEURALGIA; PAIN MEASUREMENT;

ADULT; AGED; ANALGESICS, OPIOID; CANADA; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEURALGIA; PAIN MEASUREMENT; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84940793498     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2015.05.011     Document Type: Article

References (47)

1. N. Attal, G. Cruccu, R. Baron, M. Haanpaa, P. Hansson, T.S. Jensen, T. Nurmikko European Federation of Neurological Societies EFNS Guidelines on the Pharmacological Treatment of Neuropathic Pain: 2010 Revision Eur J Neurol 17 2010 1113 1123
2. J.C. Ballantyne, and J. Mao Opioid therapy for chronic pain N Engl J Med 349 2003 1943 1953
3. D. Bouhassira, N. Attal, H. Alchaar, F. Boureau, B. Brochet, J. Bruxell, G. Cunin, J. Fermanian, P. Ginies, A. Grun-Overdyking, H. Jafari-Schluep, M. Lanteri-Minet, B. Laurent, G. Mick, A. Serrie, D. Valade, and E. Vicaut Comparison of pain syndromes associated with nervous and somatic lesions and development of a new neuropathic pain Diagnostic Questionnaire (DN4) Pain 114 2005 29 36
4. D. Bouhassira, O. Chassany, J. Gaillat, T. Hanslik, O. Launay, C. Mann, C. Rabaud, O. Rogeaux, and C. Strady Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practice Pain 153 2012 342 349
5. D. Bouhassira, M. Lanteri-Minet, N. Attal, B. Laurent, and C. Touboul Prevalence of chronic pain with neuropathic characteristics in the general population Pain 136 2008 380 387
6. H. Breivik, T. Gordh, and S. Butler Keeping an open mind: achieving balance between too liberal and too restrictive prescription of opioids for chronic non-cancer pain: using a two-edged sword Scand J Pain 3 2012 1 4
7. S. Bruehl, A.V. Akarian, J.C. Balllantyne, A. Berger, D. Borsook, W.G. Chen, J.T. Farrar, J.A. Haythornthwaite, S.D. Horn, M.J. Iadarola, C.E. Inturrisi, L. Lao, S. Mackey, J. Mao, A. Sawczuk, G.R. Uhl, J. Witter, C.J. Woolf, J.K. Zubieta, and Y. Lin Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges J Pain 14 2013 103 113
8. S. Butler, B. Jonzon, C. Branting-Ekenback, C. Wadell, and B. Farahmand Predictors of severe pain in a cohort of 5271 individuals with self-reported neuropathic pain Pain 154 2013 141 146
9. L. Colloca, and F. Benedetti Placebos and painkillers: is mind as real as matter? Neurosci Pain 6 2005 545 552
10. J. Concato, N. Shah, and R.I. Horwitz Randomized, controlled trials, observational studies and the hierarchy of research designs N Engl J Med 342 2000 1887 1892
11. R.H. Dworkin, A.B. O'Connor, J. Audette, R. Baron, G.K. Gourlay, M.L. Haanpaa, J.L. Kent, E.J. Krane, A.A. Lebel, R.M. Levy, S.C. Mackey, J. Mayer, C. Miaskowski, S.N. Raja, A.S. Rice, K.E. Schmader, B. Stacey, S. Stanos, R.D. Treede, D.C. Turk, G.A. Walco, and C.D. Wells Recommendations for the pharmacological management of neuropathic pain: an overview and literature update Mayo Clin Proc 85 2012 S3 S14
12. R.H. Dworkin, A.B. O'Connor, M. Baconja, J.T. Farrar, N.B. Finnerup, T.S. Jensen, E.A. Kalso, J.D. Loeser, C. Miaskowski, T.J. Nurmikko, R.K. Portenoy, A.S. Rice, B.R. Stacey, R.D. Treede, D.C. Turk, and M.S. Wallace Pharmacologic management of neuropathic pain: evidence-based recommendations Pain 32 2007 37 51
13. R.H. Dworkin, D.C. Turk, J.T. Farrar, J.A. Haythornthwaite, M.P. Jensen, N.P. Katz, R.D. Kerns, G. Stucki, R.R. Allen, N. Bellamy, D.B. Carr, J. Chandler, P. Cowan, R. Dionne, B.S. Galer, S. Hertz, A.R. Jadad, L.D. Kramer, D.C. Manning, S. Martin, C.G. McCormick, M.P. McDermott, P. McGrath, S. Quessy, B.A. Rappaport, W. Robbins, J.P. Robinson, M. Rothman, M.A. Royal, L. Simon, J.W. Stauffer, W. Stein, J. Tollett, J. Wernicke, and J. Witter Core outcome measures for chronic pain clinical trials: IMMPACT recommendations Pain 113 2005 9 19
14. R.H. Dworkin, D.C. Turk, M.P. McDermott, S. Peirce-Sandner, L.B. Burke, P. Cowan, J.T. Farrar, S. Hertz, S.N. Raja, R.B. Rappaport, C. Rauschkolb, and C. Sampaio Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations Pain 146 2009 238 244
15. R.H. Dworkin, D.C. Turk, K.W. Wyrwich, D. Beaton, C.S. Cleeland, J.T. Farrar, J.A. Haythornthwaite, M.P. Jensen, R.D. Kerns, D.N. Ader, N. Brandenburg, L.B. Burke, D. Cella, J. Chandler, P. Cowan, R. Dimitrova, R. Dionne, S. Hertz, A.R. Jadad, N.P. Katz, H. Kehlet, L.D. Kramer, D.C. Manning, C. McCormick, M.P. McDermott, J.H. McQuay, S. Patel, L. Porter, S. Quessy, R.A. Rappaport, C. Rauschkolb, D.A. Revicki, M. Rothman, K.E. Schmader, B.R. Stacey, J.W. Stauffer, T. van Stein, R.E. White, J. Witter, and S. Zavisic Consensus Statement. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations J Pain 9 2008 105 121
16. E. Eisenberg, E.D. MNicol, and D.B. Carr Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin JAMA 293 2005 3043 3052
17. F. Ferrini, T. Trans, T.-A.M. Mattioli, S. Laffray, T. Del-guidice, L.-E. Lorenzo, A. Castonguay, N. Doyon, W. Zhang, A.G. Godin, D. Mohr, S. Beggs, K. Vandal, J.-M. Beaulieu, C.M. Cahill, M.W. Salter, and Y. De Koninck Morphine hyperalgesia gated through microglia-mediated disruption of neuronal CI(-) homeostasis Nat Neurosci 16 2013 183 192
18. N.B. Finnerup, S.H. Sindrup, and T.S. Jensen The evidence for pharmacological treatment of neuropathic pain Pain 150 2010 573 581
19. N.B. Finnerup, N. Attal, S. Haroutounian, E. McNicol, R. Baron, R.H. Dworkin, I. Gilron, M. Haanpaa, P. Hansson, T.S. Jensen, P.R. Kamerman, K. Lund, A. Moore, S.N. Raja, A.S.C. Rice, M.R. Rowbotham, E. Sena, P. Siddall, B.H. Smith, and M. Wallace Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis Lancet Neurology 14 2015 162 173
20. O.M. Fredheim, M. Mahic, S. Skurtveit, O. Dale, P. Romundstad, and P.C. Borchgrevink Chronic pain and use of opioids: a population-based pharmacoepidemiological study from the Norwegian prescription database and the Nord-Trondelag health study Pain 155 2014 1213 1221
21. A.D. Furlan, G. Tomlinson, A.R. Jadad, and C. Bombardier Methodological quality and homogeneity influenced agreement between randomized trials and non-randomized studies of the same intervention for back pain J Clin Epidemiol 61 2008 209 231
22. I. Gilron, J.M. Bailey, D. Tu, R.R. Holden, A.C. Jackson, and R.L. Houlden Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomized controlled crossover trial Lancet 374 2009 1252 1261
23. I. Gilron, J.M. Bailey, D. Tu, R.R. Holden, D.F. Weaver, and R.L. Houlden Morphine, gabapentin or their combination for neuropathic pain N Engl J Med 352 2005 1324 1334
24. R. Gilron, C.P.N. Watson, C.M. Cahill, and D.E. Moulin Neuropathic pain: a practical guide for the clinician CMAJ 175 2006 265 275
25. A. Hinrichs-Rocker, K. Schulz, I. Jarvinen, R. Lefering, C. Simanski, and E.A. Neugebauer Psychosocial predictors and correlates for chronic post-surgical pain (CPSP)-a systematic review Eur J Pain 13 2009 719 730
26. H. Kehlet, and J.P. Rathmell Persistent postsurgical pain: the path forward through better design of clinical studies Anesthesiology 12 2010 514 515
27. M.H. Levy Pharmacologic treatment of cancer pain N Engl J Med 335 1996 1124 1132
28. M.E. Lynch, F. Campbell, A.J. Clark, M.J. Dunbar, D. Goldstein, P. Peng, J. Stinson, and H. Tupper A systematic review of the effect of waiting for treatment for chronic pain Pain 136 2008 97 116
29. R.R. Maclehose, B.C. Reeves, I.M. Harvey, T.A. Sheldon, I.T. Russell, and A.M. Black A systematic review of comparisons of effect sizes derived from randomized and non-randomized studies Health Technol Assess 4 2000 1 154
30. J. Mao Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy Pain 100 2002 213 217
31. D.E. Moulin, A. Boulanger, A.J. Clark, H. Clarke, T. Dao, G.A. Finley, A. Furlan, I. Gilron, A. Gordon, M.A. Ware, P.K. Morley-Forster, B.J. Sessle, P. Squire, J. Stinson, P. Taenzer, A. Velly, M.A. Ware, E.L. Weinberg, and O.D. Williamson Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society Pain Res Manag 19 2014 328 335
32. A.B. O'Connor, and R.H. Dworkin Treatment of neuropathic pain: an overview of recent guidelines Am J Med 122 2009 S22 S32
33. S.L. Parker, S.S. Godil, D.N. Shau, S.K. Mendenhall, and M.J. McGirt Assessment of the minimum clinically important difference in pain, disability and quality of life after anterior cervical discectomy and fusion: clinical article J Neurosurg Spine 18 2013 154 160
34. W. Rief Lessons to be learned from placebo groups in clinical trials. Commentary. 2011 International Association for the Study of Pain Pain 152 2011 1693 1694
35. P.M. Rothwell External validity of randomised controlled trials: "to whom do the results of this trial apply?" Lancet 365 2005 82 93
36. M.C. Rowbotham, I. Gilron, C. Glazer, A.S. Rice, B.H. Smith, W.F. Stewart, and A.D. Wasan Can pragmatic trials help us better understand chronic pain and improve treatment? Pain 154 2013 643 646
37. R. Soer, M.F. Reneman, P.C. Vroomen, P. Stegeman, and M.H. Coppes Responsiveness and minimally clinically important change of the pain disability index in patients with chronic back pain Spine 37 2012 711 715
38. K.A. Sporer Buprenorphine: a primer for emergency physicians Ann Emerg Med 43 2004 580 584
39. M.J. Sullivan, S.C. Bishop, and J. Pivik The Pain Catastrophizing Scale: development and validation Psychol Assess 7 1995 524 532
40. P. Thibault, P. Loisel, M.J. Durand, R. Catchlove, and M.J. Sullivan Psychological predictors of pain expression and activity intolerance in chronic pain patients Pain 139 2008 47 54
41. N. Torrance, B.H. Smith, M.I. Bennett, and A.J. Lee The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey J Pain 7 2006 281 289
42. C. Toth, and S. Au A prospective identification of neuropathic pain in specific chronic polyneuropathy syndromes and response to pharmacological therapy Pain 138 2008 657 666
43. R.D. Treede, T.S. Jensen, J.N. Campbell, G. Cruccu, J.O. Dostrovsky, J.W. Griffin, P. Hansson, R. Hughes, T. Nurmikko, and J. Serra Neuropathic pain: redefinition and a grading system for clinical and research purposes Neurology 70 2008 1630 1635
44. D.C. Turk Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain Clin J Pain 18 2002 355 365
45. D. Van der Windt, and P. Croft From the particular to the universal-how does an efficacy trial translate to practice? Pain 152 2011 967 968
46. E. Von Elm, D.G. Altman, M. Egger, S.J. Pocock, P.C. Gotzsche, J.P. Vandenbroucke STROBE Initiative The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: $$ Lancet 370 2007 1453 1457
47. C.P.N. Watson, J. Watt-Watson, and M. Chipman The long-term safety and efficacy of opioids: a survey of 84 selected patients with intractable chronic noncancer pain Pain Res Manag 15 2010 213 218